Omega Healthcare Investors shares are higher in Thursday trading as buyers rotate into income-oriented REITs and traders position ahead of the company’s next earnings report, scheduled for after the close on Tuesday, April 28, 2026, with a conference call on Wednesday, April 29, 2026. With no same-day company press release widely circulating, the move looks primarily setup-driven into the near-term catalyst and broader REIT flow dynamics.

With the earnings date approaching, investors are focused on whether Omega can sustain the cash-flow narrative it highlighted in its most recent full-year update, including continued portfolio activity and its 2026 Adjusted FFO outlook. Any commentary around operator health, rent coverage, and investment pacing will likely matter more than minor quarter-to-quarter noise given how the stock trades as a yield and credit-confidence proxy.

Attention also increased this week after Omega’s 2026 proxy statement materials began going out to shareholders around April 21, 2026, ahead of the annual meeting set for June 5, 2026. While proxy filings are typically not price-moving on their own, they can pull incremental eyes onto a stock—especially when combined with a nearby earnings catalyst.

Key watch items into the print include updates on rent collections, any changes in operator payment status, investment activity and funding costs, and dividend coverage. Investors will also monitor interest-rate sensitivity, since REIT multiples can move quickly with Treasury yield expectations even when company fundamentals are unchanged.